Novartis Raises FullYear Sales and Profit Guidance Amid Strong Operational Momentum Market Wrap Healthcare Tech Boost SP 500 as Communication Services Weighs Costcos SameStore Sales Surge 98 in Q3 Fueled by Higher Gasoline Prices and Membership Appeal Vestas Wind Systems Shares Slide After Company Warns Margins May Hit Lower End of Guidance AnheuserBusch InBev Shares Dip on Sales Miss Memorial Days Economic Impact Summer Spending Surge for Travel and Retail LANDP Q1 2026 Earnings Preferred EPS Beats Estimates Despite Negative Earnings Diversified Energy Company Q2 2024 Earnings EPS Beats Estimates by Wide Margin as Operational Discipline Pays Off TV Q1 2026 Earnings Massive EPS Surprise Amid Revenue Discrepancy AMT Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction Avino Silver Gold Mines Ltd ASM Q1 2026 Earnings Earnings Beat Strong Yet Stock Pulls Back Accuray ARAY Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Defies the Downturn Xcel Energy XEL Hovers Near 81 Amid Narrow Trading Range Wabash National WNC Edges Higher as Trailer Demand Shows Signs of Stabilization Telesat Corporation TSAT Rises 123 as Stock Approaches Key Resistance Near 6144 Signet Jewelers SIG Rallies Over 4 Key Levels to Watch Exponent Inc EXPO Declines 111 as Support Levels Come into Focus Preferred Stock ETFs Offer Steady Income Stream That May Weather Market Downturns But Investors Face Rate Risks SUPER HI INTERNATIONAL HOLDING LTD HDL Q4 2025 Earnings Limited Financial Disclosure EPS of 010 Reported GCI Liberty GLIBK Slides 322 Key Support Level at 2372 in Focus Primoris Services Corporation PRIM Q1 2026 Earnings EPS Misses Estimates Stock Gains on Operational Confidence PRHIZ Q1 2024 Earnings Strong EPS Surprise Despite No Revenue Reported ELME Q4 2025 Earnings Massive EPS Miss as Company Faces Headwinds SHLS Q1 2026 Earnings Earnings Beat Expectations on Improved Margins CLRO Q2 2018 Earnings EPS Surpasses Expectations Shares Rally CWCO Q1 2026 Earnings EPS Misses Estimates by 1327 as Stock Edges Higher Recursion Pharmaceuticals RXRX Q1 2026 Earnings Narrower Loss Surprises Market but Stock Dips on PreRevenue Status